Can emicizumab keep hemophilia joints healthy? new study aims to find out
NCT ID NCT07420348
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow about 70 people with hemophilia A who are already taking emicizumab to prevent bleeding. Researchers will use ultrasound to check for early joint damage in elbows, knees, and ankles that are currently healthy. The goal is to see how often joint damage appears over two years and what factors might be linked to it. No new treatments or changes to care are involved.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universidad de Oviedo
Oviedo, Principality of Asturias, 33006, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a clotting boost make surgery safer for hemophilia patients?
- A facelift without the bruising? tranexamic acid put to the test.
- Deep gum cleaning may boost quality of life for hemophilia patients
- Can a video call replace the clinic for hemophilia pain relief?
- Experimental drug aims to reverse liver damage in rare triple condition
- Monthly shot could free kids with hemophilia from frequent infusions